In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user pack of medicines was genuine. The measures outlined in the Falsified Medicines Directive (2011/62/EU) have been applied across the European Union (EU), with […]
The BBC has placed on its website a report on the rise in seizures of counterfeit versions of Pfizer’s branded version of sildenafil, Viagra. It is claimed in the report that young people, are experimenting with the drug, and that they are looking to illicit sources for the drug.
Unfortunately, the report does not go into detail about the claims […]
A professional development course at the University of Oxford on counterfeits and strategies to counter them:
Suspect Counterfeit Detection, Avoidance and Mitigation
with Case Histories for Nonconforming ESD Packaging Materials Used in the Shipment of Electronic Parts,
https://www.conted.ox.ac.uk/H600-12
Includes a review of how semiconductor and medical device packaging countermeasures utilize advanced material solutions.
Especially of interest to Digital Drugs this part:
Anti-Counterfeiting Measures for Packaging, […]
From Le Monde:
Raid historique d’Interpol contre les pharmacies en ligne
http://www.lemonde.fr/economie/article/2014/05/22/offensive-d-interpol-contre-les-pharmacies-illegales_4423474_3234.html
‘D’après un rapport de la Commission européenne paru en 2012, les médicaments contrefaits sont ainsi les premiers produits saisis aux frontières de l’Union européenne via le trafic postal.
… Dans le monde, 6 % à 15 % du marché mondial de médicaments relève de la contrefaçon, selon l’Organisation mondiale […]
An article on how technology is used to counter medicines counterfeits, including
mPedigree – HP joint venture for drug authentication
http://www.scidev.net/global/health/feature/fighting-fake-drugs-with-high-tech-solutions-1.html
and in closing:
“… academics, regulators and industry are rolling out new technologies to try and get a step ahead of the counterfeiters. But even the technologies’ inventors admit that nothing can replace a properly functioning national pharmaceutical regulatory […]
News from Pharma Times, Feb 24 2014
Industry concern over EU pharmacovigilance fees
“The European Federation of Pharmaceutical Industries and Associations (EFPIA), the European Generic medicines Association (EGA), the European biotech industry (EuropaBio), the Association of the European Self-Medication Industry (AESGP) and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) have issued a joint statement about their concerns for “the increasing […]
Gallery
Gallery